Webcast Alert: CEL-SCI Corp. (CVM) Announces the Biotech, Healthcare and Pharma Virtual Conference

Oct 11, 2010, 11:48 ET from CEL-SCI Corp.

VIENNA, Va., Oct. 11 /PRNewswire-FirstCall/ -- CEL-SCI Corp. (Amex: CVM) announces the following Webcast:

What:

Biotech, Healthcare and Pharma Virtual Conference

When:

October 13, 2010 @ 11:30 AM Eastern

Where:

http://www.investorcalendar.com/ClientPage.asp?ID=161779

How:

Live over the Internet -- Simply log on to the web at the address above.

Contact:

Kelley Kulick, 804-327-3433, kkulick@precisionir.com

If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=161779 or http://www.investorcalendar.com/

CEL-SCI has a first line head & neck cancer product, Multikine, cleared for Phase III testing world-wide.  Phase II studies showed the product to be safe and give a 33% increase in overall survival 42 months after surgery.  Other work is ongoing with a product that stimulates the innate immunity for the treatment/vaccination of several diseases.

SOURCE CEL-SCI Corp.